Chinook Therapeutics Inc.

KDNY | NASDAQ

Price Alert Chart Builder DCF Calculator

$40.39

+$0.09 (+0.22%)

At close: Aug 10, 2023, 04:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.71B

Enterprise Value $2.44B

Beta 0.67

Average Volume N/A

Shares Outstanding (Diluted) 71.59M

Shares Change YoY 15.5%

Institutional Ownership N/A

Exchange N/A

ISIN N/A

Price Performance

Price Change 1M N/A

Price Change 3M N/A

Price Change 6M N/A

Price Change YTD N/A

Price Change 1Y N/A

Price Change 3Y N/A

Price Change 5Y N/A

1M CAGR (ann.) 3.3%

1Y CAGR (ann.) 86.9%

5Y CAGR (ann.) 8.4%

All-Time CAGR -17.9%

Valuation

PE Ratio -11.61

Forward PE N/A

PEG Ratio 0.21

Forward PEG 0.21

PS Ratio 463.01

Forward PS N/A

PB Ratio 7.58

P/FCF Ratio -15.33

P/Adj. FCF Ratio -13.23

P/OCF Ratio -22.07

EV/Sales 418.01

EV/EBIT -14.07

EV/EBITDA -11.05

EV/FCF -13.84

Earnings Yield -8.6%

FCF Yield -6.5%

Adj. FCF Yield -7.6%

Financial Health

Net Cash $263.18M

Total Debt $33.99M

Cash & Short-Term Investments $297.17M

Total Assets $488.81M

Current Ratio 7.59

Quick Ratio 7.59

Debt / Equity Ratio 0.09

Debt / EBITDA -0.15

Debt / FCF -0.19

OCF / Debt -5.12

Interest Coverage -25.78

Altman Z-Score 10.43

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 71.9%

Operating Profit Margin -4302.1%

EBITDA Margin -2679.4%

Net Profit Margin -3012.7%

FCF Margin -3019.3%

Adj. FCF Margin -3500.2%

SBC / Revenue 327.3%

SBC Impact (per share) -15.9%

Returns

Return on Assets -32.2%

Return on Equity -41.2%

Return on Invested Capital -35.0%

Return on Capital Employed -35.4%

Return on Tangible Assets -36.0%

Historical Growth (CAGR)

Revenue CAGR 3Y 2.0%

Revenue CAGR 5Y -21.9%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -0.9%

EPS CAGR 5Y -45.7%

EPS CAGR 10Y N/A

FCF CAGR 3Y -27.7%

FCF CAGR 5Y -44.6%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 11

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Aug 4, 2024

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $30

Price Target Upside -25.7%

Cash Flow

Operating Cash Flow $-174M

Free Cash Flow $-176.6M

Adj. Free Cash Flow $-204.73M

FCF Per Share -$1.85

OCF Per Share -$1.83

OCF/S Ratio -1917.1%

Income Statement

Revenue $5.85M

Gross Profit $4.12M

Operating Income $-251.63M

EBITDA $-221.24M

Net Income $-243.21M

EPS (Diluted) -$3.48

Revenue / Employee N/A

Profit / Employee N/A

Employees N/A